Fentanyl – The Complete Medical Guide

Introduction to Fentanyl

Fentanyl is a synthetic opioid analgesic classified as a Schedule II controlled substance. With 50-100 times the potency of morphine, it’s one of the most powerful opioids available for medical use. Originally developed for cancer pain management, fentanyl is now used in various clinical settings but has also become notorious for its role in the opioid epidemic due to illicit manufacturing and distribution.

Medical Uses & Indications

FDA-Approved Uses

✅ Cancer pain management (In opioid-tolerant patients)
✅ Severe chronic pain (Transdermal patch only)
✅ Anesthesia adjunct (Surgical settings)
✅ Breakthrough cancer pain (Lozenges, sublingual tablets)

Key Clinical Features

• Potency: 50-100× morphine (IV comparison)
• Onset/Duration:

• IV: 1-2 min onset, 30-60 min duration

• Patch: 12-24 hr onset, 72 hr duration
  • DEA Classification: Schedule II (High abuse potential)

Pharmacology & Effects

Mechanism of Action

• Full μ-opioid receptor agonist
• 80-100× more lipid soluble than morphine

Therapeutic Effects

✔ Rapid, profound analgesia
✔ Minimal histamine release (vs morphine)
✔ Good hemodynamic stability

Illicit Use Dangers

• Street names: Apache, China Girl, Dance Fever
• Common adulterants: Xylazine (“tranq dope”)
• Overdose risk: 2mg can be lethal to non-tolerant users

Formulations & Dosing

Medical Formulations

Conversion Guidelines

• From morphine: 100:1 ratio (100mg morphine ≈ 1mg fentanyl)
• Patch conversion:
30mg oral morphine/day ≈ 12mcg/hr patch

Critical Safety Notes

⚠ Never initiate in opioid-naïve patients
⚠ Patch requires 72-hour disposal monitoring
⚠ Avoid heat exposure (increases absorption)

Safety Profile

Common Side Effects

• Respiratory depression
• Severe constipation
• Sedation/confusion
• Muscle rigidity (high doses)

Black Box Warnings

❌ Life-threatening respiratory depression
❌ Accidental exposure (especially children)
❌ CYP3A4 interactions
❌ Addiction/abuse potential

Overdose Management

Recognition

• Pinpoint pupils
• Respiratory rate <8
• Unconsciousness
• Cyanosis

Treatment Protocol

1. Call emergency services

2. Administer naloxone (2mg nasal preferred)

3. Supportive ventilation

4. Repeat naloxone q2-3min PRN

Harm Reduction Strategies

1. Test strips: Detect fentanyl in other drugs

2. Never use alone: Supervised consumption

3. Staggered dosing: Test small amounts first

4. Naloxone access: Keep multiple doses available

Clinical Alternatives

For Chronic Pain

• Methadone (For opioid-tolerant patients)
• Buprenorphine (Partial agonist, safer profile)
• Non-opioid adjuvants

For Acute Pain

• Hydromorphone
• Oxycodone
• Multimodal analgesia

Regulatory Considerations

• Mandatory PDMP checks
• Risk Evaluation and Mitigation Strategy (REMS)
• Special prescribing requirements in most states